Formononetin acts synergistically with a JAK2 inhibitor to suppress growth in myeloproliferative neoplasm by inhibiting JAK/STAT3 signaling pathway Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.4314/tjpr.v22i6.2
Purpose: To determine the effect of formononetin (FMNT) in the proliferation, drug resistance, and DNA damage of myeloproliferative neoplasm (MPN), and to evaluate the potential of FMNT as a therapeutic target. Methods: Cell viability curves and colony formation assays were used to characterize the proliferation of HEL or HEL/R cells. Flow cytometry was conducted to assess the apoptosis of HEL or HEL/R cells, while western blotting was performed to evaluate the expressions of DNA H2AX, DNA-PK, and Rad51, which are indicative of DNA damage, and the phosphorylation levels of JAK2 and STAT3 were determined. Results: Formononetin (FMNT) suppressed cell proliferation of HEL cells in a dose-dependent manner. It significantly reduced colony formation and promoted apoptosis of HEL cells (p < 0.05). For HEL/R cells, FMNT treatment significantly reduced cell viability, and resistance, and promoted apoptosis. Moreover, FMNT elevated H2AX levels and significantly reduced the expressions of DNA-PK and Rad51 in TG101209 (TG)-induced JAK-TKI-resistant cells (p < 0.05). Furthermore, FMNT decreased JAK2 and STAT3 phosphorylation in JAK- TKI-resistant cells. Conclusion: Treatment with FMNT represses proliferation, promotes apoptosis, weakens JAK-TKI resistance, and strengthens DNA damage in MPN cells by suppressing JAK/STAT3 pathway. This suggests that FMNT is a potential therapeutic candidate for the treatment of MPN.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.4314/tjpr.v22i6.2
- https://www.ajol.info/index.php/tjpr/article/download/250683/237003
- OA Status
- gold
- Cited By
- 2
- References
- 16
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4386259405
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4386259405Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.4314/tjpr.v22i6.2Digital Object Identifier
- Title
-
Formononetin acts synergistically with a JAK2 inhibitor to suppress growth in myeloproliferative neoplasm by inhibiting JAK/STAT3 signaling pathwayWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-07-12Full publication date if available
- Authors
-
Huijun Jiang, Zaijing Fan, Jiashan Li, Xiaoqun ZhengList of authors in order
- Landing page
-
https://doi.org/10.4314/tjpr.v22i6.2Publisher landing page
- PDF URL
-
https://www.ajol.info/index.php/tjpr/article/download/250683/237003Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.ajol.info/index.php/tjpr/article/download/250683/237003Direct OA link when available
- Concepts
-
Apoptosis, Cell growth, Viability assay, Cancer research, STAT3, Flow cytometry, Formononetin, Molecular biology, Biology, Chemistry, Biochemistry, Endocrinology, Genistein, DaidzeinTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2023: 1Per-year citation counts (last 5 years)
- References (count)
-
16Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4386259405 |
|---|---|
| doi | https://doi.org/10.4314/tjpr.v22i6.2 |
| ids.doi | https://doi.org/10.4314/tjpr.v22i6.2 |
| ids.openalex | https://openalex.org/W4386259405 |
| fwci | 0.37134082 |
| type | article |
| title | Formononetin acts synergistically with a JAK2 inhibitor to suppress growth in myeloproliferative neoplasm by inhibiting JAK/STAT3 signaling pathway |
| biblio.issue | 6 |
| biblio.volume | 22 |
| biblio.last_page | 1160 |
| biblio.first_page | 1155 |
| topics[0].id | https://openalex.org/T13426 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.983299970626831 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | Kruppel-like factors research |
| topics[1].id | https://openalex.org/T11628 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9825999736785889 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2716 |
| topics[1].subfield.display_name | Genetics |
| topics[1].display_name | Myeloproliferative Neoplasms: Diagnosis and Treatment |
| topics[2].id | https://openalex.org/T14018 |
| topics[2].field.id | https://openalex.org/fields/11 |
| topics[2].field.display_name | Agricultural and Biological Sciences |
| topics[2].score | 0.9376999735832214 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1100 |
| topics[2].subfield.display_name | General Agricultural and Biological Sciences |
| topics[2].display_name | Agriculture and Biological Studies |
| is_xpac | False |
| apc_list.value | 500 |
| apc_list.currency | USD |
| apc_list.value_usd | 500 |
| apc_paid.value | 500 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 500 |
| concepts[0].id | https://openalex.org/C190283241 |
| concepts[0].level | 2 |
| concepts[0].score | 0.6504069566726685 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q14599311 |
| concepts[0].display_name | Apoptosis |
| concepts[1].id | https://openalex.org/C62112901 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6020243167877197 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q189159 |
| concepts[1].display_name | Cell growth |
| concepts[2].id | https://openalex.org/C53227056 |
| concepts[2].level | 3 |
| concepts[2].score | 0.587661623954773 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q189152 |
| concepts[2].display_name | Viability assay |
| concepts[3].id | https://openalex.org/C502942594 |
| concepts[3].level | 1 |
| concepts[3].score | 0.5522720813751221 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[3].display_name | Cancer research |
| concepts[4].id | https://openalex.org/C2778923194 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5004627704620361 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q14912019 |
| concepts[4].display_name | STAT3 |
| concepts[5].id | https://openalex.org/C553184892 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4686552584171295 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1141429 |
| concepts[5].display_name | Flow cytometry |
| concepts[6].id | https://openalex.org/C2776578907 |
| concepts[6].level | 4 |
| concepts[6].score | 0.44801634550094604 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q408859 |
| concepts[6].display_name | Formononetin |
| concepts[7].id | https://openalex.org/C153911025 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4362432360649109 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7202 |
| concepts[7].display_name | Molecular biology |
| concepts[8].id | https://openalex.org/C86803240 |
| concepts[8].level | 0 |
| concepts[8].score | 0.3999473750591278 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[8].display_name | Biology |
| concepts[9].id | https://openalex.org/C185592680 |
| concepts[9].level | 0 |
| concepts[9].score | 0.36708348989486694 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[9].display_name | Chemistry |
| concepts[10].id | https://openalex.org/C55493867 |
| concepts[10].level | 1 |
| concepts[10].score | 0.11769476532936096 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[10].display_name | Biochemistry |
| concepts[11].id | https://openalex.org/C134018914 |
| concepts[11].level | 1 |
| concepts[11].score | 0.05657851696014404 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[11].display_name | Endocrinology |
| concepts[12].id | https://openalex.org/C2778298627 |
| concepts[12].level | 2 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q415957 |
| concepts[12].display_name | Genistein |
| concepts[13].id | https://openalex.org/C2780955279 |
| concepts[13].level | 3 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q408732 |
| concepts[13].display_name | Daidzein |
| keywords[0].id | https://openalex.org/keywords/apoptosis |
| keywords[0].score | 0.6504069566726685 |
| keywords[0].display_name | Apoptosis |
| keywords[1].id | https://openalex.org/keywords/cell-growth |
| keywords[1].score | 0.6020243167877197 |
| keywords[1].display_name | Cell growth |
| keywords[2].id | https://openalex.org/keywords/viability-assay |
| keywords[2].score | 0.587661623954773 |
| keywords[2].display_name | Viability assay |
| keywords[3].id | https://openalex.org/keywords/cancer-research |
| keywords[3].score | 0.5522720813751221 |
| keywords[3].display_name | Cancer research |
| keywords[4].id | https://openalex.org/keywords/stat3 |
| keywords[4].score | 0.5004627704620361 |
| keywords[4].display_name | STAT3 |
| keywords[5].id | https://openalex.org/keywords/flow-cytometry |
| keywords[5].score | 0.4686552584171295 |
| keywords[5].display_name | Flow cytometry |
| keywords[6].id | https://openalex.org/keywords/formononetin |
| keywords[6].score | 0.44801634550094604 |
| keywords[6].display_name | Formononetin |
| keywords[7].id | https://openalex.org/keywords/molecular-biology |
| keywords[7].score | 0.4362432360649109 |
| keywords[7].display_name | Molecular biology |
| keywords[8].id | https://openalex.org/keywords/biology |
| keywords[8].score | 0.3999473750591278 |
| keywords[8].display_name | Biology |
| keywords[9].id | https://openalex.org/keywords/chemistry |
| keywords[9].score | 0.36708348989486694 |
| keywords[9].display_name | Chemistry |
| keywords[10].id | https://openalex.org/keywords/biochemistry |
| keywords[10].score | 0.11769476532936096 |
| keywords[10].display_name | Biochemistry |
| keywords[11].id | https://openalex.org/keywords/endocrinology |
| keywords[11].score | 0.05657851696014404 |
| keywords[11].display_name | Endocrinology |
| language | en |
| locations[0].id | doi:10.4314/tjpr.v22i6.2 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S174262287 |
| locations[0].source.issn | 1596-5996, 1596-9827 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1596-5996 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Tropical Journal of Pharmaceutical Research |
| locations[0].source.host_organization | https://openalex.org/P4310311017 |
| locations[0].source.host_organization_name | Pharmacotherapy Group, University of Benin, Benin City |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311017 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.ajol.info/index.php/tjpr/article/download/250683/237003 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Tropical Journal of Pharmaceutical Research |
| locations[0].landing_page_url | https://doi.org/10.4314/tjpr.v22i6.2 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5012353814 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-7243-5431 |
| authorships[0].author.display_name | Huijun Jiang |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210105567 |
| authorships[0].affiliations[0].raw_affiliation_string | Huzhou Key Laboratory of Precision Medicine Research and Translation for Infectious Diseases, Huzhou Central Hospital, Huzhou, Zhejiang 313003, |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I114539943 |
| authorships[0].affiliations[1].raw_affiliation_string | Fifth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310000, |
| authorships[0].institutions[0].id | https://openalex.org/I4210105567 |
| authorships[0].institutions[0].ror | https://ror.org/01czx1v82 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210105567, https://openalex.org/I76130692 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | Huzhou Central Hospital |
| authorships[0].institutions[1].id | https://openalex.org/I114539943 |
| authorships[0].institutions[1].ror | https://ror.org/04epb4p87 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I114539943 |
| authorships[0].institutions[1].country_code | CN |
| authorships[0].institutions[1].display_name | Zhejiang Chinese Medical University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Huijun Jiang |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Fifth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310000,, Huzhou Key Laboratory of Precision Medicine Research and Translation for Infectious Diseases, Huzhou Central Hospital, Huzhou, Zhejiang 313003, |
| authorships[1].author.id | https://openalex.org/A5082724813 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Zaijing Fan |
| authorships[1].affiliations[0].raw_affiliation_string | Second Clinical College, |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Zaijing Fan |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Second Clinical College, |
| authorships[2].author.id | https://openalex.org/A5039917619 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Jiashan Li |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210105567 |
| authorships[2].affiliations[0].raw_affiliation_string | Huzhou Key Laboratory of Precision Medicine Research and Translation for Infectious Diseases, Huzhou Central Hospital, Huzhou, Zhejiang 313003, |
| authorships[2].institutions[0].id | https://openalex.org/I4210105567 |
| authorships[2].institutions[0].ror | https://ror.org/01czx1v82 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210105567, https://openalex.org/I76130692 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Huzhou Central Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Jiashan Li |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Huzhou Key Laboratory of Precision Medicine Research and Translation for Infectious Diseases, Huzhou Central Hospital, Huzhou, Zhejiang 313003, |
| authorships[3].author.id | https://openalex.org/A5028309511 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-9816-4833 |
| authorships[3].author.display_name | Xiaoqun Zheng |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I27781120 |
| authorships[3].affiliations[0].raw_affiliation_string | School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China |
| authorships[3].institutions[0].id | https://openalex.org/I27781120 |
| authorships[3].institutions[0].ror | https://ror.org/00rd5t069 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I27781120 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Wenzhou Medical University |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Xiaoqun Zheng |
| authorships[3].is_corresponding | True |
| authorships[3].raw_affiliation_strings | School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ajol.info/index.php/tjpr/article/download/250683/237003 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Formononetin acts synergistically with a JAK2 inhibitor to suppress growth in myeloproliferative neoplasm by inhibiting JAK/STAT3 signaling pathway |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T13426 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.983299970626831 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | Kruppel-like factors research |
| related_works | https://openalex.org/W2350822513, https://openalex.org/W2380401997, https://openalex.org/W2354594137, https://openalex.org/W2360919160, https://openalex.org/W2370523994, https://openalex.org/W3032579496, https://openalex.org/W2353925213, https://openalex.org/W3032847486, https://openalex.org/W2368861298, https://openalex.org/W2410520497 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2023 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 1 |
| best_oa_location.id | doi:10.4314/tjpr.v22i6.2 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S174262287 |
| best_oa_location.source.issn | 1596-5996, 1596-9827 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1596-5996 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Tropical Journal of Pharmaceutical Research |
| best_oa_location.source.host_organization | https://openalex.org/P4310311017 |
| best_oa_location.source.host_organization_name | Pharmacotherapy Group, University of Benin, Benin City |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311017 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.ajol.info/index.php/tjpr/article/download/250683/237003 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Tropical Journal of Pharmaceutical Research |
| best_oa_location.landing_page_url | https://doi.org/10.4314/tjpr.v22i6.2 |
| primary_location.id | doi:10.4314/tjpr.v22i6.2 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S174262287 |
| primary_location.source.issn | 1596-5996, 1596-9827 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1596-5996 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Tropical Journal of Pharmaceutical Research |
| primary_location.source.host_organization | https://openalex.org/P4310311017 |
| primary_location.source.host_organization_name | Pharmacotherapy Group, University of Benin, Benin City |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311017 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.ajol.info/index.php/tjpr/article/download/250683/237003 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Tropical Journal of Pharmaceutical Research |
| primary_location.landing_page_url | https://doi.org/10.4314/tjpr.v22i6.2 |
| publication_date | 2023-07-12 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W4229780401, https://openalex.org/W2015535501, https://openalex.org/W2135699328, https://openalex.org/W4200360099, https://openalex.org/W2964502635, https://openalex.org/W2953795527, https://openalex.org/W2980834074, https://openalex.org/W3183234149, https://openalex.org/W2903171649, https://openalex.org/W3213604254, https://openalex.org/W2170419109, https://openalex.org/W6948644336, https://openalex.org/W2807364687, https://openalex.org/W2092265336, https://openalex.org/W4214938032, https://openalex.org/W3132919412 |
| referenced_works_count | 16 |
| abstract_inverted_index.a | 28, 104, 195 |
| abstract_inverted_index.(p | 118, 154 |
| abstract_inverted_index.It | 107 |
| abstract_inverted_index.To | 1 |
| abstract_inverted_index.as | 27 |
| abstract_inverted_index.by | 186 |
| abstract_inverted_index.in | 8, 103, 149, 164, 183 |
| abstract_inverted_index.is | 194 |
| abstract_inverted_index.of | 5, 16, 25, 45, 58, 72, 81, 88, 100, 115, 145, 202 |
| abstract_inverted_index.or | 47, 60 |
| abstract_inverted_index.to | 21, 41, 54, 68 |
| abstract_inverted_index.DNA | 14, 73, 82, 181 |
| abstract_inverted_index.For | 121 |
| abstract_inverted_index.HEL | 46, 59, 101, 116 |
| abstract_inverted_index.MPN | 184 |
| abstract_inverted_index.and | 13, 20, 35, 76, 84, 90, 112, 130, 132, 140, 147, 161, 179 |
| abstract_inverted_index.are | 79 |
| abstract_inverted_index.for | 199 |
| abstract_inverted_index.the | 3, 9, 23, 43, 56, 70, 85, 143, 200 |
| abstract_inverted_index.was | 52, 66 |
| abstract_inverted_index.< | 119, 155 |
| abstract_inverted_index.Cell | 32 |
| abstract_inverted_index.FMNT | 26, 124, 136, 158, 171, 193 |
| abstract_inverted_index.Flow | 50 |
| abstract_inverted_index.H2AX | 138 |
| abstract_inverted_index.JAK- | 165 |
| abstract_inverted_index.JAK2 | 89, 160 |
| abstract_inverted_index.MPN. | 203 |
| abstract_inverted_index.This | 190 |
| abstract_inverted_index.cell | 98, 128 |
| abstract_inverted_index.drug | 11 |
| abstract_inverted_index.that | 192 |
| abstract_inverted_index.used | 40 |
| abstract_inverted_index.were | 39, 92 |
| abstract_inverted_index.with | 170 |
| abstract_inverted_index.H2AX, | 74 |
| abstract_inverted_index.HEL/R | 48, 61, 122 |
| abstract_inverted_index.Rad51 | 148 |
| abstract_inverted_index.STAT3 | 91, 162 |
| abstract_inverted_index.cells | 102, 117, 153, 185 |
| abstract_inverted_index.which | 78 |
| abstract_inverted_index.while | 63 |
| abstract_inverted_index.(FMNT) | 7, 96 |
| abstract_inverted_index.(MPN), | 19 |
| abstract_inverted_index.0.05). | 120, 156 |
| abstract_inverted_index.DNA-PK | 146 |
| abstract_inverted_index.Rad51, | 77 |
| abstract_inverted_index.assays | 38 |
| abstract_inverted_index.assess | 55 |
| abstract_inverted_index.cells, | 62, 123 |
| abstract_inverted_index.cells. | 49 |
| abstract_inverted_index.colony | 36, 110 |
| abstract_inverted_index.curves | 34 |
| abstract_inverted_index.damage | 15, 182 |
| abstract_inverted_index.effect | 4 |
| abstract_inverted_index.levels | 87, 139 |
| abstract_inverted_index.DNA-PK, | 75 |
| abstract_inverted_index.JAK-TKI | 177 |
| abstract_inverted_index.damage, | 83 |
| abstract_inverted_index.manner. | 106 |
| abstract_inverted_index.reduced | 109, 127, 142 |
| abstract_inverted_index.weakens | 176 |
| abstract_inverted_index.western | 64 |
| abstract_inverted_index.Methods: | 31 |
| abstract_inverted_index.Purpose: | 0 |
| abstract_inverted_index.Results: | 94 |
| abstract_inverted_index.TG101209 | 150 |
| abstract_inverted_index.blotting | 65 |
| abstract_inverted_index.elevated | 137 |
| abstract_inverted_index.evaluate | 22, 69 |
| abstract_inverted_index.neoplasm | 18 |
| abstract_inverted_index.pathway. | 189 |
| abstract_inverted_index.promoted | 113, 133 |
| abstract_inverted_index.promotes | 174 |
| abstract_inverted_index.suggests | 191 |
| abstract_inverted_index.JAK/STAT3 | 188 |
| abstract_inverted_index.Moreover, | 135 |
| abstract_inverted_index.Treatment | 169 |
| abstract_inverted_index.apoptosis | 57, 114 |
| abstract_inverted_index.candidate | 198 |
| abstract_inverted_index.conducted | 53 |
| abstract_inverted_index.cytometry | 51 |
| abstract_inverted_index.decreased | 159 |
| abstract_inverted_index.determine | 2 |
| abstract_inverted_index.formation | 37, 111 |
| abstract_inverted_index.performed | 67 |
| abstract_inverted_index.potential | 24, 196 |
| abstract_inverted_index.represses | 172 |
| abstract_inverted_index.treatment | 125, 201 |
| abstract_inverted_index.viability | 33 |
| abstract_inverted_index.apoptosis, | 175 |
| abstract_inverted_index.apoptosis. | 134 |
| abstract_inverted_index.indicative | 80 |
| abstract_inverted_index.suppressed | 97 |
| abstract_inverted_index.viability, | 129 |
| abstract_inverted_index.Conclusion: | 168 |
| abstract_inverted_index.expressions | 71, 144 |
| abstract_inverted_index.resistance, | 12, 131, 178 |
| abstract_inverted_index.strengthens | 180 |
| abstract_inverted_index.suppressing | 187 |
| abstract_inverted_index.therapeutic | 29, 197 |
| abstract_inverted_index.(TG)-induced | 151 |
| abstract_inverted_index.Formononetin | 95 |
| abstract_inverted_index.Furthermore, | 157 |
| abstract_inverted_index.cells.
 | 167 |
| abstract_inverted_index.characterize | 42 |
| abstract_inverted_index.formononetin | 6 |
| abstract_inverted_index.TKI-resistant | 166 |
| abstract_inverted_index.proliferation | 44, 99 |
| abstract_inverted_index.significantly | 108, 126, 141 |
| abstract_inverted_index.target.
 | 30 |
| abstract_inverted_index.dose-dependent | 105 |
| abstract_inverted_index.proliferation, | 10, 173 |
| abstract_inverted_index.phosphorylation | 86, 163 |
| abstract_inverted_index.JAK-TKI-resistant | 152 |
| abstract_inverted_index.determined.
 | 93 |
| abstract_inverted_index.myeloproliferative | 17 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5028309511 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 4 |
| corresponding_institution_ids | https://openalex.org/I27781120 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7699999809265137 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.65436601 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |